These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 20566396)
1. Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease. Rutten EP; Breyer MK; Spruit MA; Hofstra T; van Melick PP; Schols AM; Wouters EF Clin Nutr; 2010 Dec; 29(6):756-60. PubMed ID: 20566396 [TBL] [Abstract][Full Text] [Related]
2. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance? Breyer MK; Spruit MA; Celis AP; Rutten EP; Janssen PP; Wouters EF; Clin Nutr; 2009 Dec; 28(6):642-7. PubMed ID: 19540024 [TBL] [Abstract][Full Text] [Related]
3. Exercise-induced systemic effects in muscle-wasted patients with COPD. Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513 [TBL] [Abstract][Full Text] [Related]
4. Circulating visfatin in chronic obstructive pulmonary disease. Liu X; Ji Y; Chen J; Li S; Luo F Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and chronic inflammation are associated with muscle wasting in end-stage renal disease patients on hemodialysis. Rasić-Milutinović Z; Perunicić-Peković G; Ristić-Medić D; Popović T; Glibetić M; Djurić DM Gen Physiol Biophys; 2009; 28 Spec No():184-9. PubMed ID: 19893099 [TBL] [Abstract][Full Text] [Related]
6. Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease. Sergi G; Coin A; Marin S; Vianello A; Manzan A; Peruzza S; Inelmen EM; Busetto L; Mulone S; Enzi G Respir Med; 2006 Nov; 100(11):1918-24. PubMed ID: 16635565 [TBL] [Abstract][Full Text] [Related]
7. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Karadag F; Kirdar S; Karul AB; Ceylan E Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305 [TBL] [Abstract][Full Text] [Related]
8. Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD. van de Bool C; Rutten EP; Franssen FM; Wouters EF; Schols AM Eur Respir J; 2015 Aug; 46(2):336-45. PubMed ID: 25882802 [TBL] [Abstract][Full Text] [Related]
10. Circulating ghrelin in patients with chronic obstructive pulmonary disease. Luo FM; Liu XJ; Li SQ; Wang ZL; Liu CT; Yuan YM Nutrition; 2005; 21(7-8):793-8. PubMed ID: 15975486 [TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and inflammation - A further systemic complication of COPD. Bolton CE; Evans M; Ionescu AA; Edwards SM; Morris RH; Dunseath G; Luzio SD; Owens DR; Shale DJ COPD; 2007 Jun; 4(2):121-6. PubMed ID: 17530505 [TBL] [Abstract][Full Text] [Related]
13. Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD. Rutten EP; Spruit MA; Wouters EF Respir Med; 2010 Jan; 104(1):91-8. PubMed ID: 19646856 [TBL] [Abstract][Full Text] [Related]
14. Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Pobeha P; Ukropec J; Skyba P; Ukropcova B; Joppa P; Kurdiova T; Javorsky M; Klimes I; Tkac I; Gasperikova D; Tkacova R Bone; 2011 May; 48(5):1008-14. PubMed ID: 21376149 [TBL] [Abstract][Full Text] [Related]
15. Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease. Barker BL; McKenna S; Mistry V; Pancholi M; Patel H; Haldar K; Barer MR; Pavord ID; Steiner MC; Brightling CE; Bafadhel M Int J Chron Obstruct Pulmon Dis; 2014; 9():975-81. PubMed ID: 25246784 [TBL] [Abstract][Full Text] [Related]
16. The use of body mass index for measurement of fat mass in children is highly dependant on abdominal fat. El Taguri A; Dabbas-Tyan M; Goulet O; Ricour C East Mediterr Health J; 2009; 15(3):563-73. PubMed ID: 19731772 [TBL] [Abstract][Full Text] [Related]
17. The pathophysiology of cachexia in chronic obstructive pulmonary disease. Schols AM; Gosker HR Curr Opin Support Palliat Care; 2009 Dec; 3(4):282-7. PubMed ID: 19713853 [TBL] [Abstract][Full Text] [Related]
18. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease. Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM Respiration; 2009; 78(2):191-6. PubMed ID: 19270439 [TBL] [Abstract][Full Text] [Related]
19. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Wouters EF; Reynaert NL; Dentener MA; Vernooy JH Proc Am Thorac Soc; 2009 Dec; 6(8):638-47. PubMed ID: 20008867 [TBL] [Abstract][Full Text] [Related]
20. [The relationship between a decrease in fat mass and serum levels of TNF-alpha in patients with chronic obstructive pulmonary disease]. Yamamoto C; Yoneda T; Yoshikawa M; Fu A; Takenaka I; Kobayashi A; Okamura I; Okamoto Y; Tsukaguchi K; Narita N Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1191-5. PubMed ID: 9493445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]